ModivCare EBITDA Margin 2010-2025 | MODV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ModivCare (MODV) over the last 10 years. The current EBITDA margin for ModivCare as of March 31, 2025 is .
| ModivCare EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $2.75B | $0.13B | 4.65% |
| 2024-12-31 | $2.79B | $0.13B | 4.63% |
| 2024-09-30 | $2.78B | $0.14B | 5.03% |
| 2024-06-30 | $2.77B | $0.14B | 5.20% |
| 2024-03-31 | $2.77B | $0.14B | 5.16% |
| 2023-12-31 | $2.75B | $0.15B | 5.56% |
| 2023-09-30 | $2.70B | $0.14B | 5.29% |
| 2023-06-30 | $2.66B | $0.14B | 5.37% |
| 2023-03-31 | $2.59B | $0.16B | 6.09% |
| 2022-12-31 | $2.51B | $0.16B | 6.51% |
| 2022-09-30 | $2.43B | $0.17B | 7.00% |
| 2022-06-30 | $2.27B | $0.16B | 6.91% |
| 2022-03-31 | $2.12B | $0.15B | 6.95% |
| 2021-12-31 | $2.00B | $0.15B | 7.46% |
| 2021-09-30 | $1.82B | $0.14B | 7.52% |
| 2021-06-30 | $1.65B | $0.16B | 9.82% |
| 2021-03-31 | $1.46B | $0.18B | 12.14% |
| 2020-12-31 | $1.37B | $0.15B | 10.88% |
| 2020-09-30 | $1.36B | $0.13B | 9.67% |
| 2020-06-30 | $1.43B | $0.10B | 7.08% |
| 2020-03-31 | $1.51B | $0.05B | 3.11% |
| 2019-12-31 | $1.51B | $0.04B | 2.72% |
| 2019-09-30 | $1.49B | $0.04B | 2.49% |
| 2019-06-30 | $1.44B | $0.03B | 2.23% |
| 2019-03-31 | $1.42B | $0.04B | 2.89% |
| 2018-12-31 | $1.39B | $0.05B | 3.75% |
| 2018-09-30 | $1.13B | $0.07B | 6.22% |
| 2018-06-30 | $1.19B | $0.07B | 5.62% |
| 2018-03-31 | $1.26B | $0.07B | 5.57% |
| 2017-12-31 | $1.32B | $0.06B | 4.86% |
| 2017-09-30 | $1.26B | $0.07B | 5.48% |
| 2017-06-30 | $1.26B | $0.08B | 6.19% |
| 2017-03-31 | $1.25B | $0.09B | 6.96% |
| 2016-12-31 | $1.23B | $0.10B | 7.87% |
| 2016-09-30 | $1.45B | $0.05B | 3.10% |
| 2016-06-30 | $1.42B | $0.04B | 2.89% |
| 2016-03-31 | $1.44B | $0.05B | 3.47% |
| 2015-12-31 | $1.48B | $0.06B | 4.26% |
| 2015-09-30 | $1.67B | $0.12B | 7.06% |
| 2015-06-30 | $1.60B | $0.11B | 6.93% |
| 2015-03-31 | $1.53B | $0.10B | 6.48% |
| 2014-12-31 | $1.40B | $0.08B | 5.66% |
| 2014-09-30 | $1.22B | $0.06B | 4.59% |
| 2014-06-30 | $1.19B | $0.06B | 4.80% |
| 2014-03-31 | $1.13B | $0.05B | 4.69% |
| 2013-12-31 | $1.12B | $0.05B | 4.81% |
| 2013-09-30 | $1.13B | $0.06B | 4.94% |
| 2013-06-30 | $1.14B | $0.05B | 4.67% |
| 2013-03-31 | $1.13B | $0.05B | 4.08% |
| 2012-12-31 | $1.11B | $0.04B | 3.62% |
| 2012-09-30 | $1.06B | $0.04B | 3.67% |
| 2012-06-30 | $1.02B | $0.04B | 3.93% |
| 2012-03-31 | $0.98B | $0.05B | 4.72% |
| 2011-12-31 | $0.94B | $0.05B | 5.51% |
| 2011-09-30 | $0.92B | $0.06B | 6.10% |
| 2011-06-30 | $0.90B | $0.06B | 6.56% |
| 2011-03-31 | $0.89B | $0.07B | 7.45% |
| 2010-12-31 | $0.88B | $0.07B | 8.30% |
| 2010-09-30 | $0.88B | $0.08B | 8.79% |
| 2010-06-30 | $0.87B | $0.08B | 9.01% |
| 2010-03-31 | $0.84B | $0.08B | 8.97% |
| 2009-12-31 | $0.80B | $0.07B | 8.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.015B | $2.788B |
| ModivCare Inc. is a technology-enabled healthcare services company. It provides a suite of integrated supportive care solutions for public and private payors and their patients. ModivCare Inc., formerly known as The Providence Service Corporation, is based in DENVER. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.660B | 28.13 |
| CVS Health (CVS) | United States | $90.432B | 11.25 |
| Elevance Health (ELV) | United States | $71.280B | 9.59 |
| Cencora (COR) | United States | $56.729B | 18.89 |
| DiDi Global (DIDIY) | China | $27.580B | 29.30 |
| Labcorp Holdings (LH) | United States | $23.117B | 18.37 |
| Natera (NTRA) | United States | $22.728B | 0.00 |
| BioMerieux (BMXMF) | France | $17.547B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.699B | 0.00 |
| ICON (ICLR) | Ireland | $14.199B | 13.66 |
| Medpace Holdings (MEDP) | United States | $13.025B | 34.47 |
| CochLear (CHEOY) | Australia | $12.814B | 0.00 |
| Solventum (SOLV) | United States | $12.753B | 13.16 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $11.052B | 0.00 |
| Revvity (RVTY) | United States | $10.928B | 19.25 |
| Avantor (AVTR) | United States | $9.047B | 13.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.007B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.965B | 15.11 |
| HealthEquity (HQY) | United States | $7.767B | 34.02 |
| Bausch + Lomb (BLCO) | Canada | $5.289B | 35.57 |
| Sotera Health (SHC) | United States | $4.667B | 26.08 |
| BrightSpring Health Services (BTSG) | United States | $4.406B | 33.61 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| KindlyMD (NAKA) | United States | $3.810B | 0.00 |
| GeneDx Holdings (WGS) | United States | $3.696B | 84.65 |
| Alignment Healthcare (ALHC) | United States | $3.137B | 0.00 |
| Concentras Parent (CON) | United States | $3.031B | 19.23 |
| Surgery Partners (SGRY) | United States | $3.031B | 38.13 |
| Organon (OGN) | United States | $2.451B | 2.67 |
| Premier (PINC) | United States | $2.070B | 19.19 |
| Progyny (PGNY) | United States | $2.023B | 42.78 |
| Ardent Health (ARDT) | United States | $1.858B | 7.17 |
| PACS (PACS) | United States | $1.836B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.584B | 26.82 |
| Pediatrix Medical (MD) | United States | $1.481B | 9.89 |
| Teladoc Health (TDOC) | United States | $1.357B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.264B | 0.00 | |
| Omada Health (OMDA) | $1.227B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.841B | 4.92 |
| AMN Healthcare Services Inc (AMN) | United States | $0.795B | 9.83 |
| CareDx (CDNA) | United States | $0.690B | 12.72 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.599B | 0.00 |
| Agilon Health (AGL) | United States | $0.551B | 0.00 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 6.87 |
| SBC Medicals (SBC) | United States | $0.446B | 9.75 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.442B | 0.00 |
| Enhabit (EHAB) | United States | $0.415B | 27.30 |
| So-Young (SY) | China | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.354B | 0.00 |
| LifeMD (LFMD) | United States | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.280B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.194B | 0.00 |
| DocGo (DCGO) | United States | $0.168B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.145B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |